IOL Chemicals

Market Cap: Small Cap
Industry: Pharmaceuticals & Biotechnology
ISIN: INE485C01029
NSEID: IOLCP
BSEID: 524164
View on NSE | View on BSE

INR

74.26

1.43 (1.96%)

BSENSE

Mar 20

BSE+NSE Vol: 15.86 lacs

Access older stock analysis version

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Shukra Pharma.

Bliss GVS Pharma

IOL Chemicals

Morepen Labs.

Unichem Labs.

Novartis India

Hikal

Dishman Carbogen

Indoco Remedies

Panacea Biotec

Orchid Pharma

Why is IOL Chemicals & Pharmaceuticals Ltd ?

Poor long term growth as Net Sales has grown by an annual rate of 0.38% and Operating profit at 7.22% over the last 5 years

With ROE of 6.6, it has a Very Expensive valuation with a 1.2 Price to Book Value

The stock is trading at a premium compared to its peers' average historical valuations
Over the past year, while the stock has generated a return of 13.81%, its profits have risen by 27.8% ; the PEG ratio of the company is 0.6

Despite the size of the company, domestic mutual funds hold only 0.04% of the company

Domestic mutual funds have capability to do in-depth on-the-ground research on companies- their small stake may signify either they are not comfortable at the price or the business

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is IOL Chemicals for you?

High Risk, High Return

Absolute

Risk Adjusted

Volatility

IOL Chemicals

13.81%

0.31

44.95%

Sensex

-2.38%

-0.19

12.70%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

0.38%

EBIT Growth (5y)

7.22%

EBIT to Interest (avg)

10.16

Debt to EBITDA (avg)

0.52

Net Debt to Equity (avg)

-0.01

Sales to Capital Employed (avg)

1.12

Tax Ratio

26.76%

Dividend Payout Ratio

21.84%

Pledged Shares

Institutional Holding

2.11%

ROCE (avg)

9.06%

ROE (avg)

7.82%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

1.24

EV to EBIT

13.48

EV to EBITDA

9.06

EV to Capital Employed

1.25

EV to Sales

0.97

PEG Ratio

0.63

Dividend Yield

1.35%

ROCE (Latest)

8.73%

ROE (Latest)

6.62%

Loading Valuation Snapshot...

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bearish

RSI

No Signal

Bollinger Bands

Mildly Bearish

Moving Averages

Mildly Bearish (Daily)

KST

Bearish

Bullish

Dow Theory

Mildly Bearish

OBV

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

7What is working for the Company

PAT(9M)

At Rs 92.85 cr has Grown at 33.32%

NET SALES(Q)

Highest at Rs 580.39 cr

0What is not working for the Company

NO KEY NEGATIVE TRIGGERS

Loading Valuation Snapshot...

Here's what is working for IOL Chemicals

Profit After Tax (PAT) - Latest six months

At Rs 58.92 cr has Grown at 48.50%

Year on Year (YoY)

MOJO Watch

Near term PAT trend is very positive

PAT (Rs Cr)

Net Sales - Quarterly

Highest at Rs 580.39 cr and Grown

each quarter in the last five quarters

MOJO Watch

Near term sales trend is very positive

Net Sales (Rs Cr)